EHS
EHS

Dose-Dense Breast Cancer Rx Scores in Meta-Analysis

Dose-dense adjuvant chemotherapy for breast cancer leads to significant improvements in outcomes, including recurrence and overall survival (OS), compared with conventional regimens, according to a meta-analysis of 16 randomized trials.

Source link

EHS
Back to top button